Compare

AbbVie vs Pfizer

AbbVie (ABBV) and Pfizer (PFE) side by side, from official filings: what insiders, members of Congress and funds reported. These are counts of what was filed, not a view on either stock.

AbbVie ABBVNYSE · PharmaceuticalsPfizer PFENYSE · Pharmaceuticals
Insider records, last 12 months88110
Congress trades, last 12 months1211
Fund positions reported, last 12 months483207
Federal contract awards, last 12 months810
Open-market purchases by insiders since 20062525
Open-market sales by insiders since 2006537880
Last open-market purchase by an insiderMar 30, 2020Aug 12, 2026
Next resultsOct 30, 2026Nov 3, 2026

Counts of records OQRO holds, by their date. Insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned and automatic sales are included in the sales.

Common questions

Which has had more insider buying, AbbVie or Pfizer?

Since 2006, insiders of both companies reported 25 open-market purchases, in SEC Forms 4 and 5.

Do members of Congress trade ABBV or PFE?

In the last 12 months, members of Congress disclosed 12 trades in AbbVie (ABBV) and 11 in Pfizer (PFE), each reported as a value range on a periodic transaction report.

When did insiders last buy ABBV and PFE?

AbbVie: Mar 30, 2020. Pfizer: Aug 12, 2026. Dates are those of the SEC filings.

See the record behind any of these

Each company page opens free with one real filing and the counts of the last 12 months. OQRO Pro adds the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.

Get OQRO ProOpen AbbVie free$9.99 a month, cancel anytime

AbbVie pagePfizer pageRare insider trades this weekAll comparisons

https://oqro.io/compare/abbv-vs-pfe